Section 10.2. Notices.
Any notice or communication by the Company or the Trustee to the other, or by a Holder to the Company or the Trustee, is duly given if in
writing and delivered in person or mailed by first-class mail (registered or certified, return receipt requested), facsimile transmission, email or overnight air courier guaranteeing next day delivery, to the
if to the Company:
Seres Therapeutics, Inc.
Cambridge, Massachusetts 02139
Attention: Thomas DesRosier, Chief Legal Officer
with a copy to:
Latham & Watkins LLP
200 Clarendon Street, 27th Floor
Boston, Massachusetts 02116
Attention: Peter N. Handrinos
if to the Trustee:
Wilmington Trust, N.A.
Global Capital Markets
South Sixth Street, Suite 1290
Minneapolis, Minnesota 55402
Attention: Seres Therapeutics Administrator
Telephone: (612) 217-5651
The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications.
Any notice or communication to a Securityholder shall be sent electronically or by first-class mail to his, her or its address shown on
the register kept by the Registrar, in accordance with the procedures of the Depositary. Failure to send a notice or communication to a Securityholder of any Series or any defect in it shall not affect its sufficiency with respect to other
Securityholders of that or any other Series.
If a notice or communication is sent or published in the manner provided above, within the
time prescribed, it is duly given, whether or not the Securityholder receives it.
If the Company sends a notice or communication to
Securityholders, it shall send a copy to the Trustee and each Agent at the same time.